2 completed, 1 not yet recruiting. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 2 |
Follow Prurigo: new trials by email Literature Review of Prurigo trials Research Report on Prurigo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients Lebrikizumab - Prurigo Nodularis (PN) | Phase 2 | Not yet recruiting | University of Maryland, Baltimore | 15 | 2026-09-01 | 2026-09-03 |
| Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis nalbuphine HCl ER - Prurigo Nodularis, Nodularis Prurigo | Phase 2 / Phase 3 | Completed | Trevi Therapeutics | 36 | 2015-08-15 | 2025-05-21 |
| Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis nalbuphine HCl ER tablets 90 mg BID, nalbuphine HCl ER tablets 180 mg BID, Placebo tablets BID - Prurigo Nodularis, Nodularis Prurigo | Phase 2 / Phase 3 | Completed | Trevi Therapeutics | 62 | 2015-03-01 | 2025-05-21 |
Pruritus (3) · Dermatitis (1) · Skin Diseases (1)
Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Manifestations (3) · Skin and Connective Tissue Diseases (3) · Skin Diseases (2)
BID protein, human (1) · Nalbuphine (1) · Sugars (1) · lebrikizumab (1)
Trevi Therapeutics (2) · University of Maryland, Baltimore (1)
Germany (2) · United States (2) · Poland (1)